Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | FASN | P49327 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17822426 | 1.00 | ALDH1A1 (0.34) | ALDH1A1TSHRFASN | |
| SCHEMBL17822427 | 1.00 | ALDH1A1 (0.34) | ALDH1A1TSHRFASN | |
| SCHEMBL16034490 | 0.98 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL17849052 | 0.91 | — | — | |
| SCHEMBL4968606 | 0.91 | — | — | |
| SCHEMBL2041709 | 0.91 | — | — | |
| SCHEMBL16034854 | 0.91 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL979674 | 0.91 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| SCHEMBL29284292 | 0.91 | — | — | |
| SCHEMBL982345 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461072-B2 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-06-11 | — | — | US | claimed |
| US-7994086-B2 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-09 | — | — | US | claimed |
| US-20110092658-A1 | Late Transition Metal Catalysts for Olefin Oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-04-21 | — | — | US | claimed |
| US-20050003955-A1 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-01-06 | — | — | US | claimed |
| US-20040138056-A1 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-07-15 | — | — | US | claimed |
| WO-2004037837-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-05-06 | — | — | WO | claimed |
| WO-2004037869-A2 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-05-06 | — | — | WO | claimed |
| US-8461072-B2 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-06-11 | — | — | US | disclosed |
| US-7994086-B2 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-08-09 | — | — | US | disclosed |
| US-20110092658-A1 | Late Transition Metal Catalysts for Olefin Oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-04-21 | — | — | US | disclosed |
| US-7871953-B2 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2011-01-18 | — | — | US | disclosed |
| US-20050003955-A1 | Late transition metal catalysts for olefin oligomerizations | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138056-A1 | Late transition metal catalysts for olefin oligomerizations | OCIAD2, COG4, SOD1 | ALDH1A1 3468/4885TSHR 4603/4885FASN 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.